ASAM Criteria Documentation for Level-of-Care Justification

What Is ASAM Criteria Documentation?

The ASAM Criteria, published by the American Society of Addiction Medicine, is the most widely used framework in the United States for matching people with substance use disorders to an appropriate level of care. First published in 1991, it reached its Third Edition in 2013 and its Fourth Edition in 2023. Payers and state regulators use it — or criteria derived from it — to decide whether the treatment you are requesting authorization for is medically necessary at the level you are requesting.

ASAM criteria documentation, then, is not a specific form. It is the clinical writing task that sits underneath every authorization request, concurrent review, and discharge summary in substance use disorder treatment: demonstrating, with concrete clinical evidence organized across the assessment dimensions, that the client needs the level of care you are recommending — no more, no less.

This guide covers how to write that justification well. It does not reproduce The ASAM Criteria themselves. The criteria — including dimension definitions, decision rules, and assessment guides — are proprietary intellectual property of ASAM, available through asam.org. What this guide teaches is the documentation skill: how to organize your own clinical assessment so a utilization reviewer can follow your reasoning from evidence to level-of-care recommendation. The same skills that support strong medical necessity documentation generally apply here, with one added structural demand — the dimensional walk-through.

One framing point before the details: ASAM is not a regulatory body. States and payers each decide if and when to adopt a new edition. As of 2026, the 4th Edition is current, but adoption is a payer-by-payer patchwork — Optum began implementing the 4th Edition for adult determinations in late 2023, Ambetter moves adults to the 4th Edition in mid-2026 while keeping children and adolescents on the 3rd, and Illinois adopted the 4th Edition for treatment licensure effective July 1, 2025. Your documentation has to work in that mixed environment, which is covered in its own section below.

When You Need It

• Initial authorization for any ASAM-referenced level of care — withdrawal management, residential, high-intensity outpatient (formerly partial hospitalization), intensive outpatient, or outpatient services
• Concurrent review — justifying continued stay at the current level, typically every few days at higher levels of care and at longer intervals for outpatient services (see the concurrent review guide)
• Step-down or transition documentation — showing that a client is ready for a less intensive level and that the receiving level matches their current needs
• Step-up requests — documenting deterioration or emergent risk that a lower level of care cannot safely manage
• Denial appeals and peer-to-peer reviews — where the winning argument is almost always dimension-linked evidence the original submission lacked
• State licensure and audit compliance — states that have adopted The ASAM Criteria for program licensure expect assessments and placement decisions documented in dimensional terms

The Six Dimensions of the ASAM Criteria, 4th Edition

The ASAM Criteria organizes assessment around six dimensions. In the 4th Edition these are: Dimension 1, Intoxication, Withdrawal, and Addiction Medications; Dimension 2, Biomedical Conditions; Dimension 3, Psychiatric and Cognitive Conditions; Dimension 4, Substance Use-Related Risks; Dimension 5, Recovery Environment Interactions; and Dimension 6, Person-Centered Considerations. (Dimension names per The ASAM Criteria, 4th Edition; The ASAM Criteria® is a registered trademark of the American Society of Addiction Medicine, and the criteria content is copyrighted.)

At a documentation level, each dimension is a question your record needs to answer with evidence:

1. Intoxication, Withdrawal, and Addiction Medications — What is the client's current intoxication/withdrawal picture, and what is the status of addiction medication needs and management?
2. Biomedical Conditions — What physical health conditions exist, and how do they interact with treatment needs and safety?
3. Psychiatric and Cognitive Conditions — What co-occurring mental health or cognitive conditions are present, at what severity, and how do they affect the client's ability to engage safely at a given level of care?
4. Substance Use-Related Risks — What risks flow directly from the client's use pattern — continued use, dangerous use situations, likelihood of severe consequences?
5. Recovery Environment Interactions — How does the client's living situation, relationships, and daily environment support or undermine recovery?
6. Person-Centered Considerations — What barriers to care (including social determinants of health), patient preferences, and engagement/motivational needs shape what placement is actually workable?

Two structural changes from the 3rd Edition matter for writers. Readiness to change, formerly its own dimension, is now integrated across dimensions — so motivation belongs inside your dimensional narratives, tracked over time, not in a silo. And Dimension 6 is new: transportation, housing instability, childcare, work constraints, treatment availability, and the client's own preferences are now explicitly part of the placement picture and should be documented rather than left implicit.

The actual criteria within each dimension — the definitions, severity anchors, and decision rules that translate assessment into a placement decision — are in the published ASAM Criteria and are not reproduced here.

Levels of Care Quick Reference (4th Edition Numbering)

The 4th Edition continuum, as summarized by state adopters such as the Illinois Department of Human Services, runs as follows:

Level	Name
1.0	Long-Term Remission Monitoring
1.5	Outpatient Therapy
1.7	Medically Managed Outpatient
2.1	Intensive Outpatient (IOP)
2.5	High-Intensity Outpatient
2.7	Medically Managed Intensive Outpatient
3.1	Clinically Managed Low-Intensity Residential
3.5	Clinically Managed Medium/High-Intensity Residential
3.7	Medically Managed Residential
4	Medically Managed Inpatient

Two naming notes for anyone writing against a 3rd Edition mental map. First, Level 2.5 is now "High-Intensity Outpatient" — the 4th Edition retired "Partial Hospitalization" as the level name, though many payers and programs still use PHP colloquially (documentation practices for that setting are covered in the IOP/PHP documentation guide). Second, the standalone withdrawal management levels were folded into the main continuum — per ASAM's FAQ, 1-WM maps to 1.7, 2-WM to 2.7, 3.2-WM to 3.5, and 3.7-WM to 3.7 — so withdrawal management needs are now documented within the destination level rather than as a parallel track.

How to Document a Level-of-Care Justification

Strong level-of-care documentation makes a three-part argument, and it makes it dimension by dimension.

Step 1: Walk every dimension with concrete evidence

Address all six dimensions, including the ones that are unremarkable. "Dimension 2: No acute biomedical conditions; hypertension managed by PCP, medication adherent" is a finding; a skipped dimension is a hole a reviewer can fill with assumptions. For each dimension, document current severity and risk with observable, dated clinical evidence — use patterns, withdrawal signs, standardized measure scores, functional impairments, environmental facts — rather than labels. "High relapse risk" is a conclusion; "returned to daily use within 72 hours of each of two prior outpatient episodes, most recently in January when his roommate resumed selling from the apartment" is evidence.

Step 2: Make the least-restrictive argument explicitly

Reviewers are required to consider whether a lower level of care would suffice, so answer that question before they ask it. For each clinically significant dimension, state why the next level down cannot safely or effectively manage the need: "Weekly outpatient therapy was attempted from October through December with continued weekly use and two ED visits; the structure of daily programming is needed to interrupt the use pattern." A justification that never engages with the lower-level alternative reads as level-shopping.

Step 3: Match the evidence to the requested level

Close the loop: explain how the specific features of the requested level — frequency of contact, medical monitoring, structured environment, separation from the use environment — address the specific dimensional needs you documented. Then state what would need to change for the client to step down, which becomes your transition criteria and demonstrates that placement is need-driven rather than open-ended.

Language patterns that work

These are patterns for describing your own assessment, in your own words — not criteria text:

• Severity with evidence: "In the dimension addressing psychiatric conditions, Ms. R presents with moderate-severity depressive symptoms (PHQ-9 of 17 on 3/2) that impair medication adherence and follow-through with recovery activities."
• Least-restrictive rationale: "A trial of standard outpatient treatment at the current symptom level is not clinically indicated because..."
• Level match: "The daily nursing contact available at this level directly addresses the documented need for withdrawal monitoring and medication titration."
• Transition criteria: "Step-down to Level 2.1 will be appropriate when: (1) no withdrawal management needs for 7 days, (2) cravings manageable with skills between contacts, (3) sober housing confirmed."

Filled-In Example: Concurrent Review for Continued IOP (Level 2.1)

The following fictional example shows a dimension-organized continued-stay justification for an adult in intensive outpatient treatment. It documents the clinician's own multidimensional assessment; it does not reproduce ASAM Criteria content, and dimension references are to the domains named in The ASAM Criteria, 4th Edition.

What Payers Expect at Each Review Touchpoint

Payers apply ASAM-referenced criteria at three points, and the documentation burden differs at each.

Initial authorization. The full dimensional walk-through: current severity in every dimension, the least-restrictive argument, and the level match. For higher levels of care, expect to show why each lower level is insufficient, not just the next one down. This is where prior authorization documentation habits carry over directly.

Concurrent review. The question shifts from "why this level?" to "why still this level?" The most common concurrent-review failure is restating the admission picture. Every dimension rating should be updated with interval data — what improved, what has not, and why the remaining needs still exceed the next level down. Document progress honestly: a record showing no change across multiple reviews invites the conclusion that the level of care is not working, while a record showing everything resolved invites step-down. The truthful middle — specific gains, specific remaining needs, specific step-down criteria not yet met — is also the most authorizable.

Discharge and step-down. Document which transition criteria were met, the dimensional status at discharge, and the specifics of the receiving level of care (provider, frequency, first appointment). Step-down documentation that names a concrete continuing-care plan protects the client and preempts retrospective questions about whether the episode ended appropriately. Weak transition documentation is also a quiet driver of readmission denials later.

The common denial drivers, in one list: conclusory statements ("meets criteria for 3.5") without dimension-linked evidence; documentation that establishes diagnosis but never describes functional risk; dimension status never updated at concurrent review; the least-restrictive question never engaged; and discharge/transition criteria never stated. If an authorization is denied, the appeal or peer-to-peer conversation should supply exactly the dimension-linked evidence the original submission lacked — see the utilization review guide for the process mechanics.

Navigating the 3rd/4th Edition Transition

Because ASAM does not mandate adoption, 2026 is a dual-edition period, and the same clinician can face both editions in the same week. Verified examples of the patchwork: Optum began implementing the 4th Edition for adult level-of-care determinations in November 2023 (commercial plans first, Medicaid as states mandate, and only under an executed updated contract); Ambetter makes the 4th Edition its adult SUD medical-necessity tool effective June 21, 2026 while children and adolescents remain on the 3rd Edition; Illinois requires the 4th Edition for licensure as of July 1, 2025. Other states and payers are at various points, and published adoption dates circulate that are not always accurate — verify against the payer or state directly.

Practical implications for your documentation:

• Track each payer's edition in writing. Add an "edition" column to your utilization review log. When a payer notifies you of a transition date, note whether it applies to adults only.
• Watch population splits. A payer may review adults against the 4th Edition and adolescents against the 3rd. The edition follows the client, not just the payer.
• Document readiness to change longitudinally. Under the 4th Edition there is no standalone motivation dimension — weave engagement and motivational status into the relevant dimensional narratives at every review, as the example above does. Records written this way also satisfy 3rd Edition reviewers, who can find the motivational content easily.
• Document Dimension 6 explicitly. SDOH barriers, treatment availability, and patient preference are now assessable placement factors. Programs that already gather this information in the biopsychosocial assessment usually have the data — the change is surfacing it in the level-of-care justification.
• Use current level names with translation where needed. If a 3rd Edition payer expects "Partial Hospitalization" and your program has moved to 4th Edition terminology, state both: "High-Intensity Outpatient (Level 2.5; formerly Partial Hospitalization)."

ASAM publishes a free Level of Care Assessment Guide for providers, with treatment-planning and reassessment guides in development — see ASAM's implementation tools for current availability.

Compliance: ASAM Intellectual Property and AI Tools

The ASAM Criteria® is a registered trademark of the American Society of Addiction Medicine, and the criteria content is copyrighted intellectual property. Per ASAM's published FAQ, providers may use unmodified ASAM content within their own EHR for internal assessment without a permissions agreement, but any commercial or public-facing use — marketing materials, client handouts, external applications — requires a permissions agreement with ASAM. Do not copy dimension definitions, decision rules, risk-rating anchors, or assessment-guide content into public documents, program websites, or third-party tools.

ASAM also states that inputting ASAM Criteria and other ASAM intellectual property into artificial intelligence is strictly prohibited. If you use AI-assisted documentation tools, the compliant workflow is the one this entire guide describes: the tool helps you organize and articulate your own clinical assessment — your observations, severity findings, and placement rationale, in your own words — and the ASAM Criteria text stays in its licensed source. That distinction is not a technicality; it is the line between documenting a multidimensional assessment and republishing a copyrighted work.

This page is an independent educational resource for clinicians. It is not affiliated with, sponsored by, or endorsed by the American Society of Addiction Medicine. For the criteria themselves, licensing questions, and implementation tools, go to asam.org.

Common Mistakes

Writing the conclusion instead of the argument. "Client meets criteria for Level 2.1" is the sentence that should come last, after dimension-by-dimension evidence, the least-restrictive rationale, and the level match. On its own, it is the single most reliable path to a denial.

Skipping unremarkable dimensions. An unaddressed dimension reads as an unassessed dimension. Two sentences documenting a negative finding cost you nothing and close the gap.

Freezing the admission picture at concurrent review. Copy-forwarded dimensional narratives tell the reviewer either that nothing is improving or that nobody is looking. Update every dimension with interval data, dates, and scores at every review — the same discipline that drives strong substance use progress notes.

Documenting the diagnosis but not the risk. Severity of diagnosis and intensity of need are different things. Level-of-care decisions run on functional risk — what happens, concretely, if this client is treated at a lower level — and your documentation must say so.

Never stating transition criteria. A justification without step-down criteria looks open-ended, and open-ended looks unnecessary. Named, measurable transition criteria are simultaneously your strongest continued-stay argument (they are not yet met) and your discharge plan (they will be).

Treating the criteria as a copy-paste source. Reproducing ASAM text in notes destined for external submission, client handouts, or AI tools creates intellectual property exposure and, ironically, weaker documentation — reviewers want your clinical evidence, not the criteria language echoed back at them. Anchor your program's approach in your own assessment data, connected through the treatment plan and progress notes.